Results 21 to 30 of about 11,372 (280)

Echinocandins Pharmacokinetics: A Comprehensive Review of Micafungin, Caspofungin, Anidulafungin, and Rezafungin Population Pharmacokinetic Models and Dose Optimization in Special Populations. [PDF]

Clin Pharmacokinet
Albanell-Fernández M.
europepmc   +2 more sources

Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases

BMC Medicine, 2022
The severe fever with thrombocytopenia syndrome disease (SFTS), caused by the novel tick-borne SFTS virus (SFTSV), was listed among the top 10 priority infectious disease by World Health Organization due to the high fatality rate of 5–30% and the lack of
S. Shěn, Yaxian Zhang, Zhiyun Yin, Qiong Zhu, Jìngyuàn Zhāng, T. Wang, Yaohui Fang, Xiaoli Wu, Yuanzhe Bai, Shiyu Dai, Xi-Juan Liu, Jiayin Jin, Shuang Tang, Jia Liu, Manli Wang, Yu Guo, Fei Deng   +16 more
semanticscholar   +1 more source

Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillus fumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values

Pharmaceutics, 2022
Aspergillosis is an invasive fungal disease associated with high mortality. Antifungal susceptibility testing (AFST) is receiving increasing consideration for managing patients, as well as for surveilling emerging drug resistance, despite having time ...
M. Melhem, V. Coelho, C. A. Fonseca, L. Oliveira, L. Bonfietti, M. W. Szeszs, M. Magri, Francine S. Dorneles, H. Taguchi, D. V. S. Moreira, A. L. Motta, M. Batista, K. Kamei, M. Shikanai-Yasuda   +13 more
semanticscholar   +1 more source

Early Empirical Anidulafungin Reduces the Prevalence of Invasive Candidiasis in Critically Ill Patients: A Case-control Study

The Journal of Critical Care Medicine, 2022
Introduction Invasive candidiasis (IC) in critically ill patients is a serious infection with high rate of mortality. As an empirical therapy, like antibiotics, the use of antifungals is not common in intensive care units (ICUs) worldwide.
Md. Jahidul Hasan, S. Neelotpol, R. Rabbani   +2 more
semanticscholar   +1 more source

Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey [PDF]

, 2013
Background: the epidemiology of candidemia varies depending on the geographic region. Little is known about the epidemiology of candidemia in Latin America.Methods: We conducted a 24-month laboratory-based survey of candidemia in 20 centers of seven ...
Alvarado-Matute, Tito, Colombo, Arnaldo Lopes, Cortes, Jorge, Echevarria, Juan I., Elena Santolaya, Maria, Guzman-Blanco, Manuel, Latin Amer Invasive Mycosis Networ, Nora Tiraboschi, Iris, Nucci, Marcio, Queiroz-Telles, Flavio, Sifuentes-Osornio, Jose, Thompson, Luis, Zurita, Jeannete   +12 more
core   +12 more sources

DEVELOPMENT AND VALIDATION OF STABILITYINDICATING ASSAY RP-HPLC METHOD FOR THE ESTIMATION OF ANIDULAFUNGIN AND RELATED COMPOUNDS IN PARENTERAL DOSAGE FORM

RASAYAN Journal of Chemistry, 2022
RP HPLC method has been developed for the detection of Anidulafungin and to separate its related compounds. Anidulafungin was separated on a Zodiac C18 (150 × 4.6mm × 3.0µm) analytical column.
C. Tejasvini, S. Sekhar, R. Verma, L. Kumar   +3 more
semanticscholar   +1 more source

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence. [PDF]

, 2016
Aspergillus spp. are a group of filamentous molds that were first described due to a perceived similarity to an aspergillum, or liturgical device used to sprinkle holy water, when viewed under a microscope.
Stewart, Ethan R, Thompson, George R
core   +8 more sources

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazolesusceptible and -resistant Candida albicans [PDF]

Current Medical Mycology, 2022
Background and Purpose: Invasive candidiasis is a life-threatening condition that kills a large number of immunocompromised patients each year worldwide.
narges aslani, Narges Vaseghi, Majid Piramoon, shaghayegh khojasteh, Kiana Abbasi, sahar mohseni, Javad Javidnia, Behrooz Naghili   +7 more
doaj   +1 more source

Dynamics of Anidulafungin use in a Tertiary Care Hospital [PDF]

Journal of Clinical and Diagnostic Research, 2014
Dear Editor, Fungal agents have been reported to be more frequently responsible from health care associated infections in recent years [1]. New antifungal agents for invasive fungal infections are introduced to market and we wanted to evaluate our dynamics in use of one of them, the anidulafungin use in our patients with suspected invasive fungal ...
Zeliha Kocak Tufan, Rahmet Guner, Tumer Guven, Gul Ruhsar Yilmaz, Mehmet A. Tasyaran   +4 more
doaj   +7 more sources

In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017–2020

Microbiology Spectrum, 2022
To understand the changes of resistance in clinically commonly encountered fungi, we used the Antimicrobial Testing Leadership and Surveillance (ATLAS) database to explore in vitro antifungal susceptibilities against clinically important isolates of ...
Shio-Shin Jean, Hung-Jen Yang, Po-Chuen Hsieh, Yu-Tsung Huang, Wen-Chien Ko, Po-Ren Hsueh   +5 more
doaj   +1 more source